Cargando…
Evolution of anti-Trypanosoma cruzi antibody production in patients with chronic Chagas disease: Correlation between antibody titers and development of cardiac disease severity
Chagas disease is one of the most important endemic infections in Latin America affecting around 6–7 million people. About 30–50% of patients develop the cardiac form of the disease, which can lead to severe cardiac dysfunction and death. In this scenario, the identification of immunological markers...
Autores principales: | Georg, Ingebourg, Hasslocher-Moreno, Alejandro Marcel, Xavier, Sergio Salles, de Holanda, Marcelo Teixeira, Roma, Eric Henrique, Bonecini-Almeida, Maria da Gloria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536389/ https://www.ncbi.nlm.nih.gov/pubmed/28723905 http://dx.doi.org/10.1371/journal.pntd.0005796 |
Ejemplares similares
-
Is Antibody-Dependent Enhancement of Trypanosoma cruzi Infection Contributing to Congenital/Neonatal Chagas Disease?
por: Carlier, Yves, et al.
Publicado: (2021) -
Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease
por: Moreira, Otacilio C., et al.
Publicado: (2023) -
The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas
por: Ricci, Alejandro D., et al.
Publicado: (2023) -
Experimental Trypanosoma cruzi Infection and Chagas Disease—A Word of Caution
por: Talvani, André, et al.
Publicado: (2023) -
Interactive Multimedia to Teach the Life Cycle of Trypanosoma cruzi, the Causative Agent of Chagas Disease
por: Teixeira, Dirceu E., et al.
Publicado: (2012)